SIM
FLNA

Spark Investment Management’s Filana Therapeutics FLNA Stock Holding History

Spark Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-6,000
Closed -$23K – 880
2016
Q4 		$23K Sell
6,000
-11,100
-65% -$51.5K ﹤0.01% 760
2016
Q3 		$119K Buy
+17,100
New +$283K 0.01% 733
2015
Q2 		– Sell
-3,178
Closed -$41K – 726
2015
Q1 		$41K Sell
3,178
-4,308
-58% -$58.1K 0.01% 676
2014
Q4 		$106K Sell
7,486
-2,143
-22% -$37.1K 0.02% 572
2014
Q3 		$263K Sell
9,629
-6,628
-41% -$201K 0.04% 471
2014
Q2 		$653K Buy
16,257
+8,357
+106% +$309K 0.1% 297
2014
Q1 		$303K Buy
7,900
+5,914
+298% +$209K 0.05% 448
2013
Q4 		$67K Buy
+1,986
New +$52.7K 0.01% 591

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Spark Investment Management's FLNA Position: Q1 2017 in Review

Spark Investment Management sold out of Filana Therapeutics (FLNA) in Q1 2017, closing a stake of 6,000 shares — an estimated $23K sold.

Spark Investment Management first reported a position in FLNA in Q4 2013 and held it in 8 quarters. The position peaked at $653K in Q2 2014. 39 funds tracked by Wall St. Rank hold FLNA as of Q1 2017.

  • Spark Investment Management reported no remaining Filana Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Spark Investment Management sold 6,000 Filana Therapeutics shares in Q1 2017, an estimated $23K.
  • Spark Investment Management first reported a position in Filana Therapeutics in Q4 2013 and held it in 8 quarters.
  • Spark Investment Management's Filana Therapeutics position peaked at $653K in Q2 2014.
  • 39 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2017.

Based on Spark Investment Management's 13F filing for Q1 2017, filed 11 May 2017.